PEMETREXED Side Effects

7019813-5 | Alanine Aminotransferase Increased, Ascites, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Dehydration, Diarrhoea, Failure To Thrive, Haematocrit Decreased, Haemoglobin Decreased
on Sep 17, 2010 Male patient from UNITED STATES , weighting 164.0 lb, was diagnosed with non-small cell lung cancer, prophylaxis, pain (What is pain?) and was treated with Pemetrexed (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, dehydration, diarrhoea, failure to thrive, haematocrit decreased, haemoglobin decreased. Pemetrexed dosage: 500 Mg/m2, Other. During the same period patient was treated with CARBOPLATIN (6 D/f, Other) (View Carboplatin Review and Carboplatin Label ), BEVACIZUMAB (15 Mg/kg, Other) (View Bevacizumab Review and Bevacizumab Label ), NEULASTA (Unk, Other) (View Neulasta Review and Neulasta Label ), FOLIC ACID (1 Mg, Daily (1/d)) (View Folic Acid Review and Folic Acid Label ), DEXAMETHASONE (4 Mg, Other) (View Dexamethasone Review and Dexamethasone Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), BENADRYL (50 Mg, Unk) (View Benadryl Review and Benadryl Label ), MOTRIN (200 Mg, Daily (1/d)) (View Motrin Review and Motrin Label ). Patient was hospitalized.

7018889-9 | Pneumonia
Patient was taking Pemetrexed (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?) on Sep 22, 2010 from BRAZIL Additional patient health information: Female patient , weighting 100.8 lb, was diagnosed with lung neoplasm malignant and. Pemetrexed dosage: 710 Mg, Other. During the same period patient was treated with CARBOPLATIN (565 Mg, Qod) (View Carboplatin Review and Carboplatin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), MORPHINE (12 Mg, Daily (1/d)) (View Morphine Review and Morphine Label ). Patient was hospitalized.

7015250-8 | Catheter Site Infection, Dizziness
Adverse event was reported on Sep 20, 2010 by a Male patient taking Pemetrexed (View Usage) (Dosage: 500 Mg/m2, Other) was diagnosed with non-small cell lung cancer, prophylaxis and. Location: GERMANY , weighting 145.5 lb, After Pemetrexed was administered, patient had the following side effects: catheter site infection, dizziness (What is dizziness?). During the same period patient was treated with CETUXIMAB (400 Mg/m2, Loading Dose) (View Cetuximab Review and Cetuximab Label ), CISPLATIN (75 Mg/m2, Day One Every 21 Days) (View Cisplatin Review and Cisplatin Label ), FOLIC ACID (Unk, Unk) (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), CORTICOSTEROID NOS (View Corticosteroid Nos Review and Corticosteroid Nos Label ). Patient was hospitalized.

7013786-7 | Anaemia, Hypovolaemia
on Sep 13, 2010 Female patient from UNITED STATES , weighting 149.0 lb, was diagnosed with nausea (What is nausea?), back pain (What is back pain?), anxiety (What is anxiety?), hypersensitivity, depression (What is depression?), prophylaxis, dyspepsia and was treated with Pemetrexed (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, hypovolaemia. Pemetrexed dosage: 880 Mg, Other. During the same period patient was treated with COMPAZINE (30 Mg, Every 8 Hrs) (View Compazine Review and Compazine Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ), LORAZEPAM (1.5 Mg, Every 6 Hrs) (View Lorazepam Review and Lorazepam Label ), ZYRTEC (10 Mg, Daily (1/d)) (View Zyrtec Review and Zyrtec Label ), CELEXA (10 Mg, Daily (1/d)) (View Celexa Review and Celexa Label ), VITAMIN B 12 (15.9 Ug, Other) (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (800 Mg, Daily (1/d)) (View Folic Acid Review and Folic Acid Label ), PROTONIX (40 Mg, Daily (1/d)) (View Protonix Review and Protonix Label ). Patient was hospitalized.


7012205-4 | Pancreatitis Acute
on Sep 16, 2010 Male patient from JAPAN , 52 years of age, weighting 116.8 lb, was diagnosed with lung adenocarcinoma stage iv and was treated with Pemetrexed (View Usage). Patient had the following side effects: pancreatitis acute. Pemetrexed dosage: 800 Mg, Unk. During the same period patient was treated with PANVITAN (1 G, Daily (1/d), 0.5 Mg/d As Folic Acid) (View Panvitan Review and Panvitan Label ), HYDROXOCOBALAMINE (1 Mg, Unk) (View Hydroxocobalamine Review and Hydroxocobalamine Label ), SOL MELCORT (125 Mg, Unk) (View Sol-melcort Review and Sol-melcort Label ), KYTRIL (1 D/f, Unk) (View Kytril Review and Kytril Label ), DEXART (1.65 Mg, Unk) (View Dexart Review and Dexart Label ), DECADRON (View Decadron Review and Decadron Label ), PRIMPERAN TAB (1 D/f, 2/d) (View Primperan Tab Review and Primperan Tab Label ). Patient was hospitalized.

7012051-1 | No Adverse Event
Patient was taking Pemetrexed (View Usage). After Pemetrexed was administered, patient had the following side effects: no adverse event on Sep 16, 2010 from JAPAN Additional patient health information: Male patient , 41 years of age, was diagnosed with non-small cell lung cancer and. Pemetrexed dosage: 500 Mg/m2, Other. During the same period patient was treated with PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), VITAMIN B12 /00056201/ (1 Mg, Daily (1/d)) (View Vitamin B12 /00056201/ Review and Vitamin B12 /00056201/ Label ).

7009739-5 | Respiratory Arrest
Adverse event was reported on Sep 16, 2010 by a Male patient taking Pemetrexed (View Usage) (Dosage: 500 Mg/m2, Day 1 Every 21 Days) was diagnosed with non-small cell lung cancer, prophylaxis and. Location: INDIA , weighting 94.80 lb, Patient experienced the following unwanted or unexpected effects: respiratory arrest. During the same period patient was treated with CISPLATIN (75 Mg/m2, Day 1 Every 21 Days) (View Cisplatin Review and Cisplatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MORPHINE (View Morphine Review and Morphine Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ).

7009738-3 | Pulmonary Embolism
on Sep 14, 2010 Male patient from UNITED STATES , weighting 179.4 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Pemetrexed (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Pemetrexed dosage: 500 Mg/m2, On Day 1 Every 21 Days. During the same period patient was treated with CARBOPLATIN (6 D/f, On Day 1 Every 21 Days) (View Carboplatin Review and Carboplatin Label ), BEVACIZUMAB (15 Mg/kg, On Day One Every 21 Days) (View Bevacizumab Review and Bevacizumab Label ), FOLIC ACID (Unk, Unk) (View Folic Acid Review and Folic Acid Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), ANZEMET (View Anzemet Review and Anzemet Label ), LORTAB (View Lortab Review and Lortab Label ).

7006637-8 | Chronic Obstructive Pulmonary Disease, Condition Aggravated
on Sep 21, 2010 Female patient from UNITED STATES , weighting 173.5 lb, was diagnosed with non-small cell lung cancer and was treated with Pemetrexed (View Usage). After Pemetrexed was administered, patient had the following side effects: chronic obstructive pulmonary disease, condition aggravated. Pemetrexed dosage: 400mg/m2 Iv Q2 Weeks. During the same period patient was treated with GEMCITABINE (1200mg/m2 Q2 Weeks) (View Gemcitabine Review and Gemcitabine Label ), AVASTIN (10mg/kg Q2 Weeks) (View Avastin Review and Avastin Label ), COMBIVENT (View Combivent Review and Combivent Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CRESTOR (View Crestor Review and Crestor Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), VICODIN (View Vicodin Review and Vicodin Label ). Patient was hospitalized.

7005766-2 | Anaemia, Asthenia, Dyspnoea, Fatigue
Patient was taking Pemetrexed (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, asthenia, dyspnoea, fatigue on Sep 09, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 183.0 lb, was diagnosed with non-small cell lung cancer, pain (What is pain?), antiemetic supportive care, hypertension, prophylaxis and. Pemetrexed dosage: 500 Mg/m2, Every 21 Days. During the same period patient was treated with CARBOPLATIN (6 Auc Every 21 Days) (View Carboplatin Review and Carboplatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), ZOFRAN (View Zofran Review and Zofran Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ). Patient was hospitalized.

7002204-0 | Cardiomyopathy
Adverse event was reported on Sep 08, 2010 by a Male patient taking Pemetrexed (View Usage) (Dosage: 980 Mg, Other) was diagnosed with non-small cell lung cancer and. Location: GERMANY , weighting 176.4 lb, Patient had the following side effects: cardiomyopathy (What is cardiomyopathy?). During the same period patient was treated with CISPLATIN (147 Mg, Other) (View Cisplatin Review and Cisplatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CONCOR (View Concor Review and Concor Label ), ENAHEXAL /00574902/ (View Enahexal /00574902/ Review and Enahexal /00574902/ Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), KALITRON (View Kalitron Review and Kalitron Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ). Patient was hospitalized.

7000093-1 | Ileus, Large Intestine Carcinoma
on Sep 10, 2010 Male patient from JAPAN , 66 years of age, weighting 103.2 lb, was diagnosed with lung adenocarcinoma stage iv, gastritis, insomnia and was treated with Pemetrexed (View Usage). After Pemetrexed was administered, patient had the following side effects: ileus, large intestine carcinoma. Pemetrexed dosage: 775 Mg, Other. During the same period patient was treated with GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ), DEXART (View Dexart Review and Dexart Label ), PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), HYDROXOCOBALAMINE (1 Mg, Unk) (View Hydroxocobalamine Review and Hydroxocobalamine Label ), GASTER D (View Gaster D Review and Gaster D Label ), DEPAS (View Depas Review and Depas Label ). Patient was hospitalized.

7000086-4 | Hypertension
on Sep 07, 2010 Female patient from UNITED STATES , weighting 138.0 lb, was diagnosed with non-small cell lung cancer and was treated with Pemetrexed (View Usage). Patient experienced the following unwanted or unexpected effects: hypertension. Pemetrexed dosage: 890 Mg, Every 3 Weeks. During the same period patient was treated with CISPLATIN (130 Mg, Every 3 Weeks) (View Cisplatin Review and Cisplatin Label ), AG 013736(AXITINIB) (5 Mg, 2/d) (View Ag-013736(axitinib) Review and Ag-013736(axitinib) Label ).

7000084-0 | Gastrointestinal Disorder
Patient was taking Pemetrexed (View Usage). Patient had the following side effects: gastrointestinal disorder on Sep 07, 2010 from JAPAN Additional patient health information: Male patient , 61 years of age, weighting 135.4 lb, was diagnosed with lung adenocarcinoma stage iii and. Pemetrexed dosage: 500 Mg/m2, Other. During the same period patient was treated with CISPLATIN (75 Mg/m2, Unk) (View Cisplatin Review and Cisplatin Label ), PANVITAN (1 G (contains 0.5mg Folic Acid), Daily (1/d)) (View Panvitan Review and Panvitan Label ), HYDROXOCOBALAMIN ACETATE (1 Mg, Every 9 Weeks) (View Hydroxocobalamin Acetate Review and Hydroxocobalamin Acetate Label ). Patient was hospitalized.

7000082-7 | Syncope
Adverse event was reported on Sep 14, 2010 by a Male patient taking Pemetrexed (View Usage) (Dosage: 500 Mg/m2, Other) was diagnosed with non-small cell lung cancer and. Location: UNITED STATES , weighting 187.8 lb, After Pemetrexed was administered, patient had the following side effects: syncope. During the same period patient was treated with CARBOPLATIN (6 D/f, Other) (View Carboplatin Review and Carboplatin Label ), BEVACIZUMAB (15 Mg/kg, Other) (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

7000080-3 | Haemorrhoids, Rectal Ulcer
on Sep 10, 2010 Female patient from JAPAN , 45 years of age, weighting 82.23 lb, was diagnosed with lung adenocarcinoma stage iv, anxiety disorder, metastases to central nervous system and was treated with Pemetrexed (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhoids, rectal ulcer. Pemetrexed dosage: 600 Mg, Other. During the same period patient was treated with CISPLATIN (95 Mg, Other) (View Cisplatin Review and Cisplatin Label ), PANVITAN (1 G, Daily (1/d), 0.5 Mg/d As Folic Acid) (View Panvitan Review and Panvitan Label ), HYDROXOCOBALAMINE (1 Mg, Unk) (View Hydroxocobalamine Review and Hydroxocobalamine Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ), DEXART (View Dexart Review and Dexart Label ), EMEND (View Emend Review and Emend Label ), DEPAS (View Depas Review and Depas Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

6991496-X | Dehydration, Dyspnoea
on Sep 09, 2010 Male patient from UNITED STATES , weighting 333.9 lb, was diagnosed with non-small cell lung cancer, depression (What is depression?), diabetes mellitus, back pain (What is back pain?), insomnia, hypertension, chronic obstructive pulmonary disease and was treated with Pemetrexed (View Usage). Patient had the following side effects: dehydration, dyspnoea. Pemetrexed dosage: 500 Mg/m2, On Day 1 Every 21 Days. During the same period patient was treated with BEVACIZUMAB (15 Mg/kg, On Day 1 Every 21 Days) (View Bevacizumab Review and Bevacizumab Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), METFORMIN (View Metformin Review and Metformin Label ), OXYCODONE WITH APAP (View Oxycodone With Apap Review and Oxycodone With Apap Label ), TRAZODIL (View Trazodil Review and Trazodil Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6991494-6 | Dyspnoea
Patient was taking Pemetrexed (View Usage). After Pemetrexed was administered, patient had the following side effects: dyspnoea on Sep 07, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 181.0 lb, was diagnosed with non-small cell lung cancer and. Pemetrexed dosage: 500 Mg/m2, Other. During the same period patient was treated with CARBOPLATIN (6 D/f, Other) (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6991493-4 | Headache
Adverse event was reported on Sep 03, 2010 by a Female patient taking Pemetrexed (View Usage) (Dosage: 500 Mg/m2, Monthly (1/m)) was diagnosed with non-small cell lung cancer and. Location: UNITED STATES , 30 years of age, weighting 118.8 lb, Patient experienced the following unwanted or unexpected effects: headache (What is headache?). During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), KEPPRA (View Keppra Review and Keppra Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (1 Mg, Unk) (View Folic Acid Review and Folic Acid Label ), DECADRON (View Decadron Review and Decadron Label ), IMODIUM (View Imodium Review and Imodium Label ), ZOFRAN (View Zofran Review and Zofran Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

6991492-2 | Epistaxis, Febrile Neutropenia, Neutrophil Count Decreased, Platelet Count Decreased
on Sep 07, 2010 Male patient from UNITED STATES , weighting 242.5 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and was treated with Pemetrexed (View Usage). Patient had the following side effects: epistaxis, febrile neutropenia, neutrophil count decreased, platelet count decreased. Pemetrexed dosage: 500 Mg/m2, Other. During the same period patient was treated with CETUXIMAB (400 Mg/m2, Other) (View Cetuximab Review and Cetuximab Label ), CARBOPLATIN (5 D/f, Other) (View Carboplatin Review and Carboplatin Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ZOFRAN (View Zofran Review and Zofran Label ), COMPAZINE (View Compazine Review and Compazine Label ). Patient was hospitalized.

6991491-0 | Mallory-weiss Syndrome, Vomiting
on Sep 06, 2010 Female patient from KOREA, REPUBLIC OF , weighting 106.9 lb, was diagnosed with non-small cell lung cancer metastatic, prophylaxis, nausea (What is nausea?), neuralgia and was treated with Pemetrexed (View Usage). After Pemetrexed was administered, patient had the following side effects: mallory-weiss syndrome, vomiting. Pemetrexed dosage: 500 Mg/m2 On Day 1 Every 21 Days. During the same period patient was treated with CISPLATIN (75 Mg/m2 On Day 1 Every 21 Days) (View Cisplatin Review and Cisplatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.

6983880-5 | Gastrointestinal Haemorrhage
Patient was taking Pemetrexed (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage on Sep 03, 2010 from ITALY Additional patient health information: Male patient , weighting 154.3 lb, was diagnosed with non-small cell lung cancer, prophylaxis and. Pemetrexed dosage: 500 Mg/m2, Day 1 Every 21 Days. During the same period patient was treated with CISPLATIN (75 Mg/m2, Day 1 Every 21 Days) (View Cisplatin Review and Cisplatin Label ), BEVACIZUMAB (7.5 Mg/kg, Day 1 Every 21 Days) (View Bevacizumab Review and Bevacizumab Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6979743-1 | Erysipelas, Pleural Effusion
Adverse event was reported on Sep 03, 2010 by a Male patient taking Pemetrexed (View Usage) (Dosage: 500 Mg/m2, On Day 1 Every 21 Days) was diagnosed with non-small cell lung cancer, prophylaxis and. Location: GERMANY , weighting 205.0 lb, Patient had the following side effects: erysipelas, pleural effusion. During the same period patient was treated with CISPLATIN (75 Mg/m2, On Day 1 Every 21 Days) (View Cisplatin Review and Cisplatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6979742-X | Fatigue, Pancytopenia
on Sep 07, 2010 Male patient from UNITED KINGDOM , 56 years of age, weighting 149.9 lb, was diagnosed with mesothelioma (What is mesothelioma?), prophylaxis and was treated with Pemetrexed (View Usage). After Pemetrexed was administered, patient had the following side effects: fatigue, pancytopenia. Pemetrexed dosage: 900 Mg, Day 1 Every Three Weeks. During the same period patient was treated with CISPLATIN (135 Mg, Day 1 Every Three Weeks) (View Cisplatin Review and Cisplatin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), INFUMORPH (View Infumorph Review and Infumorph Label ), ORAMORPH SR (View Oramorph Sr Review and Oramorph Sr Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6979741-8 | Pancytopenia
on Sep 06, 2010 Female patient from ITALY , weighting 154.3 lb, was diagnosed with non-small cell lung cancer, prophylaxis and was treated with Pemetrexed (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia. Pemetrexed dosage: 500 Mg/m2, Other (day I Evey 21 Days). During the same period patient was treated with CETUXIMAB (400 Mg/m2, Other (day 1 Every 21 Days)) (View Cetuximab Review and Cetuximab Label ), CISPLATIN (75 Mg/m2, Other (day One Every 21 Days)) (View Cisplatin Review and Cisplatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ANTIHISTAMINES (View Antihistamines Review and Antihistamines Label ), LANSOPRAZOL (View Lansoprazol Review and Lansoprazol Label ).

6978882-9 | Epistaxis, Febrile Neutropenia, Neutrophil Count Decreased, Platelet Count Decreased
Patient was taking Pemetrexed (View Usage). Patient had the following side effects: epistaxis, febrile neutropenia, neutrophil count decreased, platelet count decreased on Sep 01, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 242.5 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and. Pemetrexed dosage: 500 Mg/m2, Other. During the same period patient was treated with CETUXIMAB (400 Mg/m2, Other) (View Cetuximab Review and Cetuximab Label ), CARBOPLATIN (5 D/f, Other) (View Carboplatin Review and Carboplatin Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ZOFRAN (View Zofran Review and Zofran Label ), COMPAZINE (View Compazine Review and Compazine Label ). Patient was hospitalized.

6976719-5 | Cerebral Infarction, Disease Progression, Pneumonia, Thrombophlebitis, Vena Cava Thrombosis
Adverse event was reported on Sep 06, 2010 by a Female patient taking Pemetrexed (View Usage) (Dosage: 500 Mg/m2, Unk) was diagnosed with lung adenocarcinoma stage iv, gastric ulcer, anxiety disorder and. Location: JAPAN , 41 years of age, weighting 97.00 lb, After Pemetrexed was administered, patient had the following side effects: cerebral infarction, disease progression, pneumonia (What is pneumonia?), thrombophlebitis, vena cava thrombosis. During the same period patient was treated with PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), METHYCOBAL (1 Mg, Unk) (View Methycobal Review and Methycobal Label ), GRANISETRON /01178102/ (Unk, Unk) (View Granisetron /01178102/ Review and Granisetron /01178102/ Label ), DECADRON /00016002/ (View Decadron /00016002/ Review and Decadron /00016002/ Label ), PARIET /JPN/ (Unk, Unk) (View Pariet /jpn/ Review and Pariet /jpn/ Label ), MUCODYNE (Unk, Unk) (View Mucodyne Review and Mucodyne Label ), MUCOSOLVAN (Unk, Unk) (View Mucosolvan Review and Mucosolvan Label ), RIZE (Unk, Unk) (View Rize Review and Rize Label ). Patient was hospitalized.

6976712-2 | Herpes Zoster
on Aug 30, 2010 Female patient from KOREA, REPUBLIC OF , weighting 126.3 lb, was diagnosed with non-small cell lung cancer, dyspepsia, prophylaxis against gastrointestinal ulcer and was treated with Pemetrexed (View Usage). Patient experienced the following unwanted or unexpected effects: herpes zoster. Pemetrexed dosage: . During the same period patient was treated with CISPLATIN (75 Mg/m2, Unk) (View Cisplatin Review and Cisplatin Label ), FOLIC ACID (1 Mg, Daily (1/d)) (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (1000 Mg, Unk) (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (8 Mg, Unk) (View Dexamethasone Review and Dexamethasone Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MEGESTROL (View Megestrol Review and Megestrol Label ). Patient was hospitalized.

6976184-8 | Atrial Fibrillation, Blood Sodium Decreased, Fall, Syncope
on Sep 03, 2010 Male patient from JAPAN , 73 years of age, weighting 105.4 lb, was diagnosed with lung adenocarcinoma, prophylaxis, abdominal discomfort, decreased appetite, nausea (What is nausea?) and was treated with Pemetrexed (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood sodium decreased, fall (What is fall?), syncope. Pemetrexed dosage: 500 Mg/m2, Other. During the same period patient was treated with CISPLATIN (75 Mg/m2, Other) (View Cisplatin Review and Cisplatin Label ), PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), PARIET (10 Mg, Daily (1/d)) (View Pariet Review and Pariet Label ), PRIMPERAN TAB (10 Mg, Daily (1/d)) (View Primperan Tab Review and Primperan Tab Label ), EMEND (Unk, Daily (1/d)) (View Emend Review and Emend Label ), HYDROXOCOBALAMIN ACETATE (View Hydroxocobalamin Acetate Review and Hydroxocobalamin Acetate Label ).

6976180-0 | Haemoglobin Decreased, Muscular Weakness, Pyrexia
Patient was taking Pemetrexed (View Usage). After Pemetrexed was administered, patient had the following side effects: haemoglobin decreased, muscular weakness, pyrexia on Aug 31, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 184.3 lb, was diagnosed with non-small cell lung cancer and. Pemetrexed dosage: 500 Mg/m2 (1005mg), Once Every 21 Days. During the same period patient was treated with GEMCITABINE HCL (1250 Mg/m2 (2512mg), On Day 1 And 8 Every 21 Days) (View Gemcitabine Hcl Review and Gemcitabine Hcl Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), POTASSIUM GLUCONATE TAB (View Potassium Gluconate Tab Review and Potassium Gluconate Tab Label ), ESTER C (View Ester-c Review and Ester-c Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), LASIX (View Lasix Review and Lasix Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6974869-0 | Pyothorax
Adverse event was reported on Sep 02, 2010 by a Female patient taking Pemetrexed (View Usage) (Dosage: 500 Mg/m2, Other) was diagnosed with lung adenocarcinoma stage iv, diabetes mellitus and. Location: JAPAN , 73 years of age, weighting 101.4 lb, Patient experienced the following unwanted or unexpected effects: pyothorax. During the same period patient was treated with CISPLATIN (75 Mg/m2, Other) (View Cisplatin Review and Cisplatin Label ), DECADRON (View Decadron Review and Decadron Label ), GRANISETRON HCL (Unk, Unk) (View Granisetron Hcl Review and Granisetron Hcl Label ), PANVITAN (1 G, Unk) (View Panvitan Review and Panvitan Label ), METHYCOBAL (1 Mg, Unk) (View Methycobal Review and Methycobal Label ), JUZENTAIHOTO (View Juzentaihoto Review and Juzentaihoto Label ), BASEN (View Basen Review and Basen Label ), AMARYL (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6974868-9 | Bronchitis, Febrile Neutropenia
on Sep 08, 2010 Male patient from HUNGARY , weighting 165.3 lb, was diagnosed with non-small cell lung cancer, prophylaxis, hypertonia, gastrooesophageal reflux disease, dyspnoea, superior vena caval occlusion and was treated with Pemetrexed (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), febrile neutropenia. Pemetrexed dosage: 500 Mg/m2, Q3w. During the same period patient was treated with TARCEVA (150 Mg, Daily (1/d)) (View Tarceva Review and Tarceva Label ), FOLIC ACID (1 D/f, Daily (1/d)) (View Folic Acid Review and Folic Acid Label ), VIT B12 (1000 Ug, Daily (1/d)) (View Vit B12 Review and Vit B12 Label ), METHYLPREDNISOLONE ACETATE (View Methylprednisolone Acetate Review and Methylprednisolone Acetate Label ), LOSARTAN POTASSIUM (50 Mg, Unk) (View Losartan Potassium Review and Losartan Potassium Label ), LANSOPRAZOL (30 Mg, Unk) (View Lansoprazol Review and Lansoprazol Label ), THEOSPIREX (150 Mg, 2/d) (View Theospirex Review and Theospirex Label ), MEDROL (8 Mg, Unk) (View Medrol Review and Medrol Label ).

6971718-1 | Enterocolitis, Renal Impairment
on Aug 30, 2010 Male patient from JAPAN , 66 years of age, weighting 108.0 lb, was diagnosed with lung adenocarcinoma stage iv, cough, constipation (What is constipation?) and was treated with Pemetrexed (View Usage). After Pemetrexed was administered, patient had the following side effects: enterocolitis, renal impairment. Pemetrexed dosage: 760 Mg (500mg/m2), Other. During the same period patient was treated with CISPLATIN (115 Mg (75 Mg/m2), Other) (View Cisplatin Review and Cisplatin Label ), PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), HYDROXOCOBALAMIN ACETATE (1 Mg, Daily (1/d)) (View Hydroxocobalamin Acetate Review and Hydroxocobalamin Acetate Label ), CODEINE PHOSPHATE (Unk, Unk) (View Codeine Phosphate Review and Codeine Phosphate Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), PANTOSIN (View Pantosin Review and Pantosin Label ), PURSENNID /00571902/ (View Pursennid /00571902/ Review and Pursennid /00571902/ Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

6971715-6 | Intestinal Perforation, Non-cardiac Chest Pain, Peritonitis, Syncope, Vomiting
Patient was taking Pemetrexed (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal perforation, non-cardiac chest pain, peritonitis, syncope, vomiting on Aug 27, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 123.9 lb, was diagnosed with non-small cell lung cancer, gastrooesophageal reflux disease, antiemetic supportive care, constipation (What is constipation?), hypertension, pain (What is pain?) and. Pemetrexed dosage: 500 Mg/m2, Other. During the same period patient was treated with CARBOPLATIN (6 D/f, Other) (View Carboplatin Review and Carboplatin Label ), BEVACIZUMAB (15 Mg/kg, Other) (View Bevacizumab Review and Bevacizumab Label ), ALUMINIUM HYDROXIDE W/ MAGNESIUM HYDROXIDE (View Aluminium Hydroxide W/ Magnesium Hydroxide Review and Aluminium Hydroxide W/ Magnesium Hydroxide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), MORPHINE SULFATE (Unk, Unk) (View Morphine Sulfate Review and Morphine Sulfate Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6971714-4 | Disease Progression, Diverticulum Intestinal Haemorrhagic, Hepatic Encephalopathy
Adverse event was reported on Sep 02, 2010 by a Male patient taking Pemetrexed (View Usage) (Dosage: 500 Mg/m2, Other) was diagnosed with lung adenocarcinoma stage iv, prophylaxis and. Location: JAPAN , 67 years of age, weighting 156.5 lb, Patient had the following side effects: disease progression, diverticulum intestinal haemorrhagic, hepatic encephalopathy. During the same period patient was treated with CARBOPLATIN (625 Mg, Other) (View Carboplatin Review and Carboplatin Label ), PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), METHYCOBAL (1 Mg, Other) (View Methycobal Review and Methycobal Label ), DECADRON (View Decadron Review and Decadron Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ). Patient was hospitalized.

6970450-8 | Hypocalcaemia
on Aug 27, 2010 Female patient from IRELAND , weighting 107.4 lb, was diagnosed with non-small cell lung cancer, prophylaxis, laxative supportive care and was treated with Pemetrexed (View Usage). After Pemetrexed was administered, patient had the following side effects: hypocalcaemia. Pemetrexed dosage: 750 Mg, Every 3 Weeks. During the same period patient was treated with CISPLATIN (113 Mg, Every 3 Weeks) (View Cisplatin Review and Cisplatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), SENNA (View Senna Review and Senna Label ). Patient was hospitalized.

6970449-1 | Dehydration, Neutrophil Count Decreased, Platelet Count Decreased, White Blood Cell Count Decreased
on Aug 27, 2010 Male patient from UNITED STATES , weighting 128.0 lb, was diagnosed with non-small cell lung cancer and was treated with Pemetrexed (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Pemetrexed dosage: 860 Mg, Other. During the same period patient was treated with CARBOPLATIN (575 Mg, Other) (View Carboplatin Review and Carboplatin Label ), FOLIC ACID (1 Mg, Daily (1/d)) (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (1000 Ug, Other) (View Vitamin B-12 Review and Vitamin B-12 Label ), K TAB (10 Meq, Unk) (View K-tab Review and K-tab Label ), ZOFRAN (8 Mg, 3/d) (View Zofran Review and Zofran Label ). Patient was hospitalized.

6969993-2 | Malignant Neoplasm Progression, Nephrogenic Diabetes Insipidus, Renal Failure Chronic, Tubulointerstitial Nephritis
Patient was taking Pemetrexed (View Usage). Patient had the following side effects: malignant neoplasm progression, nephrogenic diabetes insipidus, renal failure chronic, tubulointerstitial nephritis on Aug 30, 2010 from GREECE Additional patient health information: Male patient , 57 years of age, was diagnosed with non-small cell lung cancer and. Pemetrexed dosage: 500 Mg/m2, D1 Every 21 Days. During the same period patient was treated with VITAMIN B 12 (1 G, Every 60 Days) (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (350 Mg, Daily (1/d)) (View Folic Acid Review and Folic Acid Label ), DEXAMETHASONE (4 Mg, Bid For 3 Days) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6968166-7 | C-reactive Protein Increased
Adverse event was reported on Aug 26, 2010 by a Male patient taking Pemetrexed (View Usage) (Dosage: 760 Mg, Other) was diagnosed with lung adenocarcinoma stage iii, prophylaxis and. Location: JAPAN , 73 years of age, weighting 116.8 lb, After Pemetrexed was administered, patient had the following side effects: c-reactive protein increased. During the same period patient was treated with PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), HYDROXOCOBALAMIN ACETATE (1 Mg, Other) (View Hydroxocobalamin Acetate Review and Hydroxocobalamin Acetate Label ), RINDERON (View Rinderon Review and Rinderon Label ). Patient was hospitalized.

6966032-4 | Pulmonary Embolism
on Sep 03, 2010 Male patient from UNITED STATES , weighting 194.0 lb, was diagnosed with non-small cell lung cancer, prophylaxis, insomnia and was treated with Pemetrexed (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). Pemetrexed dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), NEXIUM (View Nexium Review and Nexium Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), FOLSAN (View Folsan Review and Folsan Label ), VIT B12 (View Vit B12 Review and Vit B12 Label ), MAGNESIUM VERLA /02088501/ (View Magnesium Verla /02088501/ Review and Magnesium Verla /02088501/ Label ). Patient was hospitalized.

6965110-3 | Anaemia
on Aug 25, 2010 Male patient from UNITED STATES , weighting 221.9 lb, was diagnosed with non-small cell lung cancer, prophylaxis, hypercholesterolaemia, pain management, anxiety (What is anxiety?), nausea (What is nausea?) and was treated with Pemetrexed (View Usage). Patient had the following side effects: anaemia. Pemetrexed dosage: 500 Mg/m2, Other. During the same period patient was treated with CARBOPLATIN (Unk, Other) (View Carboplatin Review and Carboplatin Label ), BEVACIZUMAB (15 Mg/kg, Other) (View Bevacizumab Review and Bevacizumab Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), PROCHLORPERAZINE MALEATE (View Prochlorperazine Maleate Review and Prochlorperazine Maleate Label ). Patient was hospitalized.

6962592-8 | Atrial Fibrillation, Blood Sodium Decreased, Fall, Syncope
Patient was taking Pemetrexed (View Usage). After Pemetrexed was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood sodium decreased, fall (What is fall?), syncope on Aug 23, 2010 from JAPAN Additional patient health information: Male patient , 73 years of age, weighting 105.4 lb, was diagnosed with lung adenocarcinoma, prophylaxis, abdominal discomfort, decreased appetite, nausea (What is nausea?) and. Pemetrexed dosage: 500 Mg/m2, Other. During the same period patient was treated with CISPLATIN (75 Mg/m2, Other) (View Cisplatin Review and Cisplatin Label ), PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), PARIET (10 Mg, Daily (1/d)) (View Pariet Review and Pariet Label ), PRIMPERAN TAB (10 Mg, Daily (1/d)) (View Primperan Tab Review and Primperan Tab Label ), EMEND (Unk, Daily (1/d)) (View Emend Review and Emend Label ).

6962591-6 | Thrombocytopenia
Adverse event was reported on Aug 20, 2010 by a Male patient taking Pemetrexed (View Usage) (Dosage: 500 Mg/m2, Other) was diagnosed with lung adenocarcinoma and. Location: JAPAN , weighting 98.55 lb, Patient experienced the following unwanted or unexpected effects: thrombocytopenia. During the same period patient was treated with CARBOPLATIN (Unk, Other) (View Carboplatin Review and Carboplatin Label ), PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ). Patient was hospitalized.

6962590-4 | Haemoptysis, Hyponatraemia
on Aug 24, 2010 Male patient from UNITED STATES , weighting 112.4 lb, was diagnosed with non-small cell lung cancer stage iv, dyspnoea, nausea (What is nausea?), prophylaxis and was treated with Pemetrexed (View Usage). Patient had the following side effects: haemoptysis, hyponatraemia. Pemetrexed dosage: 500 Mg/m2 On Day 1 Every 21 Days. During the same period patient was treated with CARBOPLATIN (6 Auc On Day 1 Every 21 Days) (View Carboplatin Review and Carboplatin Label ), BEVACIZUMAB (15 Mg/kg On Day 1 Every 21 Days) (View Bevacizumab Review and Bevacizumab Label ), COMBIVENT (View Combivent Review and Combivent Label ), PHENERGAN (View Phenergan Review and Phenergan Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6962589-8 | Gastrointestinal Haemorrhage, Renal Failure
on Aug 23, 2010 Male patient from UNITED KINGDOM , weighting 194.0 lb, was diagnosed with non-small cell lung cancer and was treated with Pemetrexed (View Usage). After Pemetrexed was administered, patient had the following side effects: gastrointestinal haemorrhage, renal failure. Pemetrexed dosage: 500 Mg/m2, Every 3 Weeks. During the same period patient was treated with FOLIC ACID (1000 Ug, Unk) (View Folic Acid Review and Folic Acid Label ), METYLPREDNISOLON SOLUBILE (40 Mg,3 X 3 Week) (View Metylprednisolon Solubile Review and Metylprednisolon Solubile Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ). Patient was hospitalized.

6962588-6 | Device Malfunction
Patient was taking Pemetrexed (View Usage). Patient experienced the following unwanted or unexpected effects: device malfunction on Aug 20, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 135.0 lb, was diagnosed with non-small cell lung cancer, prophylaxis and. Pemetrexed dosage: 500 Mg/m2, Other. During the same period patient was treated with CARBOPLATIN (6 D/f, Other) (View Carboplatin Review and Carboplatin Label ), BEVACIZUMAB (10 Mg/kg, Other) (View Bevacizumab Review and Bevacizumab Label ), CALCIUM W/VITAMIN D /00188401/ (View Calcium W/vitamin D /00188401/ Review and Calcium W/vitamin D /00188401/ Label ), ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE (View Albuterol Sulfate And Ipratropium Bromide Review and Albuterol Sulfate And Ipratropium Bromide Label ), FEXOFENADINE HCL (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), PREMPRO (View Prempro Review and Prempro Label ), CRESTOR (View Crestor Review and Crestor Label ).

6961649-5 | Back Pain, Facial Paresis
Adverse event was reported on Aug 19, 2010 by a Female patient taking Pemetrexed (View Usage) (Dosage: 500 Mg/m2, Day 1 Every 21 Days) was diagnosed with non-small cell lung cancer, prophylaxis and. Location: GERMANY , weighting 209.4 lb, Patient had the following side effects: back pain (What is back pain?), facial paresis. During the same period patient was treated with CISPLATIN (75 Mg/m2, Day 1 Every 21 Days) (View Cisplatin Review and Cisplatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ZOPICLON (View Zopiclon Review and Zopiclon Label ). Patient was hospitalized.

6961647-1 | Haemoglobin Decreased, Muscular Weakness, Pyrexia
on Aug 19, 2010 Male patient from UNITED STATES , weighting 184.3 lb, was diagnosed with non-small cell lung cancer and was treated with Pemetrexed (View Usage). After Pemetrexed was administered, patient had the following side effects: haemoglobin decreased, muscular weakness, pyrexia. Pemetrexed dosage: 500 Mg/m2 (1005mg), Once Every 21 Days. During the same period patient was treated with GEMCITABINE HCL (1250 Mg/m2 (2512mg), On Day 1 And 8 Every 21 Days) (View Gemcitabine Hcl Review and Gemcitabine Hcl Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), POTASSIUM GLUCONATE TAB (View Potassium Gluconate Tab Review and Potassium Gluconate Tab Label ), ESTER C (View Ester-c Review and Ester-c Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), LASIX (View Lasix Review and Lasix Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6958118-5 |
on Aug 20, 2010 Male patient from INDIA , weighting 123.5 lb, was diagnosed with non-small cell lung cancer, hypertension and was treated with Pemetrexed (View Usage). . Pemetrexed dosage: 500 Mg/m2, On D1 Cyclical. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

6955435-X | Pneumonia
Patient was taking Pemetrexed (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?) on Aug 18, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 188.2 lb, was diagnosed with non-small cell lung cancer stage iv, chronic obstructive pulmonary disease, hypertension, prophylaxis, diabetes mellitus and. Pemetrexed dosage: 500 Mg/m2, Other. During the same period patient was treated with CARBOPLATIN (6 D/f, Other) (View Carboplatin Review and Carboplatin Label ), BEVACIZUMAB (15 Mg/kg, Other) (View Bevacizumab Review and Bevacizumab Label ), ATROVENT (View Atrovent Review and Atrovent Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), GLUCOTROL (View Glucotrol Review and Glucotrol Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.